AIRS
Airsculpt Technologies, Inc.Company Information
- Company Name
- Airsculpt Technologies, Inc.
- CIK
- CIK0001870940
- Category
- <br>Emerging growth company
- Ticker: Exchange
- AIRS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8011
- SIC Description
- Services-Offices & Clinics of Doctors of Medicine
- Ticker
- AIRS
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-04-17
- Last sale
- 2024-11-15
- Shares purchased (TTM)
- 1,739,268
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 40,752,802
- Shares outstanding
- 70,786,163
- Ownership
- 57.57%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- 1.64%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 19 | 17 | 8 | 5 | 8 | 6 | 8 | 6 | 10 | 11 | 10 | 9 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 27 | 24 | 15 | 12 | 16 | 15 | 17 | 13 | 22 | 15 | 16 | 16 | ||||||
| Income Taxes Receivable | 2 | 2 | 1 | 3 | 2 | 3 | 3 | 3 | 3 | 0 | 2 | 4 | ||||||
| Prepaid Expense And Other Assets Current | 6 | 6 | 6 | 3 | 6 | 6 | 6 | 4 | 8 | 4 | 4 | 3 | ||||||
| Property Plant And Equipment Net | 24 | 26 | 28 | 30 | 34 | 36 | 37 | 36 | 32 | 30 | 29 | 29 | ||||||
| Other Assets Noncurrent | 3 | 3 | 3 | 3 | 6 | 7 | 5 | 6 | 4 | 6 | 6 | 3 | ||||||
| Operating Lease Right Of Use Asset | 22 | 21 | 22 | 21 | 22 | 23 | 29 | 28 | 27 | 25 | 25 | 26 | ||||||
| Finite Lived Intangible Assets Net | 34 | 36 | 37 | 38 | 39 | 40 | 42 | 43 | 44 | 45 | 46 | 48 | ||||||
| Goodwill | 82 | 82 | 82 | 82 | 82 | 82 | 82 | 82 | 82 | 82 | 82 | 82 | ||||||
| Assets | 193 | 192 | 187 | 186 | 198 | 203 | 213 | 208 | 210 | 203 | 204 | 204 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 7 | 7 | 5 | 4 | 3 | 4 | 6 | 7 | 5 | 4 | 4 | 4 | ||||||
| Employee Related Liabilities Current | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 2 | 4 | 4 | ||||||
| Long Term Debt Current | 10 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | 3 | 2 | 2 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 35 | 32 | 28 | 24 | 26 | 27 | 29 | 25 | 25 | 22 | 20 | 20 | ||||||
| Contract With Customer Liability Current | 3 | 4 | 2 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 2 | ||||||
| Accrued Liabilities Current | 4 | 6 | 5 | 5 | 8 | 8 | 8 | 4 | 8 | 5 | 3 | 3 | ||||||
| Operating Lease Liability Current | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | ||||||
| Long Term Debt Noncurrent | 33 | 39 | 51 | 52 | 53 | 64 | 65 | 66 | 68 | 69 | 70 | 71 | ||||||
| Deferred Income Tax Liabilities Net | 1 | 1 | 1 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 5 | ||||||
| Operating Lease Liability Noncurrent | 20 | 19 | 20 | 21 | 22 | 23 | 28 | 26 | 24 | 22 | 23 | 23 | ||||||
| Long Term Line Of Credit | - | - | 0 | 0 | 0 | 5 | 5 | - | - | - | 0 | - | ||||||
| Other Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 0 | 1 | 1 | ||||||
| Liabilities | 88 | 92 | 100 | 104 | 107 | 126 | 135 | 126 | 125 | 119 | 120 | 120 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 149 | 143 | 128 | 125 | 124 | 109 | 108 | 105 | 102 | 97 | 104 | 99 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 105 | 100 | 88 | 82 | 90 | 76 | 78 | 83 | 85 | 84 | 84 | 84 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -2 | -2 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -44 | -43 | -41 | -41 | -31 | -31 | -29 | -23 | -17 | -14 | -20 | -15 | ||||||
| Liabilities And Stockholders Equity | 193 | 192 | 187 | 186 | 198 | 203 | 213 | 208 | 210 | 203 | 204 | 204 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 450 | 450 | 450 | 450 | 450 | 450 | 450 | 450 | 450 | 450 | 450 | 450 | ||||||
| Common Stock Shares Issued | 72 | 71 | 64 | 62 | 62 | 59 | 58 | 58 | 58 | 58 | 57 | 57 | ||||||
| Shares Outstanding | 72 | 71 | 64 | 62 | 62 | 59 | 58 | 58 | 58 | 58 | 57 | 57 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialAirsculpt Technologies, Inc. (AIRS) — SEC Financial Statements & Analysis
Airsculpt Technologies, Inc. (AIRS) is a services-offices & clinics of doctors of medicine company. Airsculpt Technologies, Inc. trades on Nasdaq as: AIRS. Airsculpt Technologies, Inc. (AIRS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, Airsculpt Technologies, Inc. carries a market cap of $318.54M, a P/E ratio of -27.14x, a P/B ratio of 3.04x, a P/S ratio of 2.11x, an enterprise value of $343.28M, and an EV/EBITDA multiple of -1030.88x. On profitability, it posts a gross margin of 59.73%, an operating margin of -8.35%, a net margin of -7.79%, a Return on Equity (ROE) of -12.05%, a Return on Assets (ROA) of -5.99%, and a Return on Invested Capital (ROIC) of -6.05%. Per share, it reports EPS of $-0.17, diluted EPS of $-0.17, free cash flow per share of $0.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -8.71% year-over-year, net income growth of -17.80% year-over-year, and EPS growth of -30.80% year-over-year. On the balance sheet, it maintains a current ratio of 0.79x, a quick ratio of 0.61x, working capital of $-7.45M, a debt-to-equity ratio of 0.84x, a debt ratio of 0.46, an interest coverage ratio of -2.45x, free cash flow of $760.00K (TTM), and net debt of $24.74M. Figures sourced from SEC EDGAR.
- Market Cap
- $318.54M
- P/E TTM
- -27.14x
- EPS TTM
- $-0.17
- P/B TTM
- 3.04x
- ROE TTM
- -12.05%
- ROA TTM
- -5.99%
- Debt To Equity
- 0.84x
- Free Cash Flow TTM
- $760.00K
- Net Revenue TTM Growth 1Y
- -8.71%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Airsculpt Technologies, Inc. in?
Airsculpt Technologies, Inc. (AIRS) operates in the Services-Offices & Clinics of Doctors of Medicine industry.
What exchange does AIRS trade on?
Airsculpt Technologies, Inc. (AIRS) trades on the Nasdaq.
When was Airsculpt Technologies, Inc. (AIRS)'s most recent SEC filing?
Airsculpt Technologies, Inc. (AIRS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is AIRS's market cap?
Airsculpt Technologies, Inc. (AIRS) has a market capitalization of $318.54M as of 2026-06-30.
What is AIRS's EPS (earnings per share)?
Airsculpt Technologies, Inc. (AIRS)'s trailing twelve month EPS is $-0.17 as of 2026-06-30.
What is AIRS's ROE (return on equity)?
Airsculpt Technologies, Inc. (AIRS)'s trailing twelve month Return on Equity (ROE) is -12.05% as of 2026-06-30.
What is AIRS's ROA (return on assets)?
Airsculpt Technologies, Inc. (AIRS)'s trailing twelve month Return on Assets (ROA) is -5.99% as of 2026-06-30.
What is AIRS's ROIC (return on invested capital)?
Airsculpt Technologies, Inc. (AIRS)'s trailing twelve month Return on Invested Capital (ROIC) is -6.05% as of 2026-06-30.
What is AIRS's EV/EBITDA?
Airsculpt Technologies, Inc. (AIRS)'s trailing twelve month EV/EBITDA is -1030.88x as of 2026-06-30.